Kessler Foundation Receives $1 M Grant to Study Benefits of Ekso Bionics' Ekso GT™ Exoskeleton
Feb 03, 2016 21:01 pm UTC| Business
RICHMOND, Calif., Feb. 03, 2016 -- Kessler Foundation, a global leader in rehabilitation research, announced today that it will use the Ekso GT™ of Ekso Bionics (OTCQB:EKSO) in a multi-center randomized controlled trial...
Fate Therapeutics to Present at Leerink Partners 5th Annual Global Healthcare Conference
Feb 03, 2016 21:01 pm UTC| Business
SAN DIEGO, Feb. 03, 2016 -- Fate Therapeutics, Inc. (NASDAQ:FATE), a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for cancer and immune disorders, announced today that...
Skyline Medical to Present at Source Capital Group’s 2016 Disruptive Growth & Healthcare Conference
Feb 03, 2016 21:00 pm UTC| Business
MINNEAPOLIS, Feb. 03, 2016 -- Skyline Medical Inc. (NASDAQ:SKLN)(NASDAQ:SKLNU) today announced that Josh Kornberg, President and CEO, will provide a company overview at the Source Capital Group’s 2016 Disruptive Growth ...
Immunomedics Announces Second Quarter Fiscal 2016 Results and Clinical Program Developments
Feb 03, 2016 21:00 pm UTC| Business
MORRIS PLAINS, N.J., Feb. 03, 2016 -- Immunomedics, Inc., (Nasdaq:IMMU) today reported financial results for the second quarter ended December 31, 2015. The Company also highlighted recent key developments and planned...
Pacific Biosciences Announces Fourth Quarter 2015 Financial Results
Feb 03, 2016 21:00 pm UTC| Business
MENLO PARK, Calif., Feb. 03, 2016 -- Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced financial results for its fourth quarter ended December 31, 2015. Revenue for the fourth quarter of 2015...
Cytokinetics to Participate in Upcoming Investor Conferences
Feb 03, 2016 21:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 03, 2016 -- Cytokinetics, Inc. (Nasdaq:CYTK) announced today that Robert I. Blum, President and Chief Executive Officer, is scheduled to present at the 18th Annual BIO CEO Investor...
Feb 03, 2016 21:00 pm UTC| Business
SCHAUMBURG, Ill., Feb. 03, 2016 -- Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) a leader of specialty pharmaceutical products with a specific emphasis on the injectable market, today announced that it will release...